FKBP12.6 ‘Stabilises’ Cardiac SR Ca2+-Release by Antagonising High-Affinity Reversible Activation of RyR2 by FKBP12  by Galfrè, Elena et al.
560a Wednesday, March 9, 2011conjunction with elevated SR Ca2þ load to generate spontaneous Ca2þwaves in
rabbit cardiomyocytes.
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Regulation of Sarcoplasmic Reticulum [Ca2D] during Rest in Rabbit
Ventricular Myocytes
Elisa Bovo, Aleksey V. Zima.
During diastole, ryanodine receptor Ca2þ release channels are not completely
quiescent, thus providing a pathway for significant sarcoplasmic reticulum
(SR) Ca2þ leak. Cytosolic Ca2þ can be pumped back into the SR by the SR
Ca2þ-ATPase (SERCA) or extruded by Naþ-Ca2þ exchanger (NCX). There-
fore, the activity of Ca2þ transport systems during diastole plays a critical
role in setting SR Ca2þ load under normal conditions and in disease states. Us-
ing confocal microscopy, we studied mechanisms that control intra-SR free
Ca2þ ([Ca2þ]SR) at rest in rabbit ventricular myocytes. We compared the rate
of [Ca2þ]SR decline (with Fluo-5N) after rest from electrical pacing in control
conditions and after SERCA inhibition with thapsigargin (TG; 10 mM). We
found that the rate of [Ca2þ]SR decline increased only ~30% after SERCA
blockade compared to control conditions (from 10.9 in control to 14.1 mM/s
in the presence of TG). Similar results were obtained by measuring the rate
of decline of total SR Ca2þ content, estimated from caffeine-induced Ca2þ tran-
sient amplitude (with Fluo-4). Inhibition of NCX by Ni2þ (5 mM) or by 0
[Naþ]/0[Ca2þ] solution significantly slowed [Ca2þ]SR decline during rest (by
3.4 times), but did not prevent it. Simultaneous inhibition of NCX with 0
[Naþ]/0[Ca2þ] solution and plasmalemmal Ca2þ ATPase with La3þ (1 mM)
completely prevented [Ca2þ]SR decline during rest. These results indicate
that in rabbit ventricular myocytes the predominant mechanism for cytosolic
Ca2þ removal during rest is NCX but not SERCA-mediated Ca2þ uptake.
These data are compatible with a model in which the majority of SR Ca2þ
leak occurs through clusters of ryanodine receptors in the junctional SR that
closely oppose NCX in the dyadic cleft.
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Increased Myofilament Ca2D Sensitivity Decreases Sarcomere Length and
Increases Spark-Spark Interactions
Ye Chen-Izu, Tamas Banyasz, Shaden Khabbaz, Stephanie Edelmann,
Charles Payne, Jil C. Tardiff, Leighton T. Izu.
People with familial hypertrophic cardiomyopathy (FHC) harboring mutations
of cardiac troponin T (cTnT) are often at a high risk of sudden cardiac death.
Transgenic mice harboring some of these cTnT mutations show increased myo-
filament sensitivity to Ca2þ and also shortened diastolic sarcomere length (SL).
Our computational studies predicted that decreasing the distances between
Ca2þ release units (CRUs) of the sarcoplasmic reticulum (SR) by decreasing
SL can destabilize the Ca2þ control system and increase the probability of
spontaneous Ca2þ waves. Destabilization results from enhanced crosstalk be-
tween neighboring CRUs. In this study we mimic the greater myofilament
Ca2þ sensitivity conferred by cTnT mutations using the myofilament Ca2þ sen-
sitizer EMD 57033 (EMD). At concentrations up to 3 mM, EMD had no effect
on either the peak Ca2þ transient or the diastolic Ca2þ levels and did not alter
the SR Ca2þ load. To test the prediction that SL shortening increases the cou-
pling between CRUs, we loaded myocytes with Di8-ANEPPS and Fluo-4 and
simultaneously measured SL and Ca2þ sparks in 2 spatial dimensions using
the Zeiss 5 Live high-speed 2-D scanning confocal microscope. EMD (1.5 mM)
decreased SL significantly compared to the control cells in normal Tyrode
(1.58 mm vs.1.69 mm, p<0.05). The spark coupling strength measures the influ-
ence of one CRU on another and is derived from an analysis of the spatio-
temporal distribution of Ca2þ sparks. EMD treatment significantly increased
the spark coupling strength 2.5 fold. The enhanced spark-spark coupling as
diastolic SL decreases may contribute to increased frequency of spontaneous
Ca2þ waves during diastole that can lead to triggered arrhythmias and sudden
cardiac death in FHC.
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RyR2 Channel Activity Determines the Potency of State-Dependent RyR2
Blockers for Suppressing Arrhythmogenic Calcium Waves
Eleonora Savio Galimberti, Bjorn C. Knollmann.
Mutations in ryanodine receptors (RyR2) or calsequestrin (casq2) cause cate-
cholaminergic- polymorphic ventricular tachycardia (CPVT).We previously re-
ported that the RyR2 open-channel blocker flecainide (FLEC) suppresses Ca2þ
waves and prevents CPVT in mice and humans. Here we test the hypothesis that
the open-state block by FLEC significantly contributes to FLEC efficacy in
CPVT. We reasoned that FLEC would preferentially affect myocytes lacking
casq2 (casq2-/-),whichhave higher rates of spontaneousRyR2channel openings
compared toWT channels. To test this hypothesis, we compared FLECwith tet-
racaine, a RyR2 channel blocker that has no state dependence and binds equallywell to closed RyR2 channels. We found that FLEC reduced the incidence, am-
plitude and frequency of Ca2þ waves with significantly higher potency in
casq2-/- myocytes compared to WT myocytes (Figure). In contrast, tetracaine
did not suppress Ca2þ waves and had equal potency in WT and casq2-/- myo-
cytes (Figure). Conclusion: RyR2 channel activity likely determines the potency
of open-state
RyR2 blockers
such as FLEC
for suppressing
arrhythmogenic
Ca2þ waves,
a mechanism
likely relevant
to FLEC antiar-
rhythmic effi-
cacy in CPVT.
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FKBP12.6 ‘Stabilises’ Cardiac SR Ca2D-Release by Antagonising High-
Affinity Reversible Activation of RyR2 by FKBP12
Elena Galfre`, Mano Sitsapesan, Samantha J. Pitt, Elisa Venturi,
Stephen O’Neill, Rebecca Sitsapesan.
FKBP12.6 is thought to play an important cardioprotective role, however, the
underlying mechanism is not understood. Since FKBP12 is structurally similar
to FKBP12.6 but is found at much higher levels (1-3 mM), we investigated the
effects of both FKBP12 and FKBP12.6 on RyR2 single-channel function and
on SR Ca2þ-release in rat isolated permeabilised cardiomyocytes. FKBP12 in-
creased RyR2 open probability (Po) in a concentration-dependent, reversible
manner (EC50 51 nM). Physiological levels of FKBP12 (3 mM) increased Po
from 0.18750.051 to 0.65750.111 (SEM; n=14; P<0.001). FKBP12.6
(200 nM), itself, did not significantly alter RyR2 Po, but was a very effective
antagonist of FKBP12, shifting the FKBP12 EC50 to 4 mM. In permeabilised
myocytes perfused with Fluo-5F, spontaneous waves of Ca2þ-induced Ca2þ-re-
lease were induced by 234 nM Ca2þ in the mock cytosolic solution. Perfusion
with FKBP12 (3 mM) increased wave frequency from 0.3450.04 Hz to
0.5250.07 Hz (SEM; n=14; p<0.03). 10 mM caffeine produced a larger
Ca2þ-transient in control (2.2150.11; F/Fo) than in FKBP12 (1.4750.16;
n=6; p<0.003) indicating lower SR Ca2þ-content. Perfusion with FKBP12.6
(200 nM) alone, had no significant effect yet it reduced the ability of
FKBP12 to increase wave frequency (49.955.8% increase over control in
the absence of FKBP12.6 vs. 16.252.1% in the presence). Our single-
channel experiments demonstrate that FKBP12 is a high affinity, potent activa-
tor of RyR2. FKBP12.6 acts as an antagonist of FKBP12 at RyR2 but itself
possesses minimal efficacy. Our cellular experiments suggest that this is the un-
derlying mechanism by which FKBP12.6 acts to ‘stabilise’ or reduce SR Ca2þ-
release in cardiac cells. Thus, the balance between the opposing actions
of FKBP12 and FKBP12.6 on RyR2 gating may be crucial for normal
EC-coupling in cardiac cells.
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Increased Levels of Micrornas miR-1 and miR-133 in Failing Heart Underlie
Dissociation of Phosphatase Activity from RyR2 Complex Resulting in En-
hancedRyR2CaMKII-DependentPhosphorylationandCardiacArrhythmias
Andriy E. Belevych, Sarah E. Sansom, Radmila Terentyeva,
Mickey M. Martin, Cynthia A. Carnes, Terry S. Elton, Sandor Gyorke,
Dmitry Terentyev.
Increased propensity of ventricular myocytes to arrhythmogenic spontaneous
SR Ca release and afterdepolarizations in heart failure (HF) has been linked
to abnormally high activity of RyR2. Growing evidence supports hyperphos-
phorylation of RyR2 at the CaMKII site S-2814 as a potential mechanism for
altered RyR2 function. However, the specific molecular mechanisms underly-
ing RyR2 hyperphosphorylation remain poorly understood.
MicroRNAs are small noncoding RNAs that regulate protein expression
by interfering with mRNAs of target genes. We recently reported that
2-fold overexpession of microRNA miR-1 enhances CaMKII-dependent
RyR2 phosphorylation by disrupting protein phosphatase 2A scaffolding to
the RyR2, resulting in increased activity of the channel and Ca-dependent
afterdepolarizations in myocytes. In the present study, we used a canine model
of nonischemic HF to test the hypothesis that the HF-related alterations in
RyR2 phosphorylation levels are caused by a decrease in phosphatase activity
localized to RyR2 due to enhanced expression of two most abundant muscle-
specific microRNAs miR-1 and miR-133. qRT-PCR studies revealed that the
